Dai Chihara, Ruitao Lin, Alexander Boardman, Ryan C. Lynch, David M. Kurtz, Mazyar Shadman, Alex F. Herrera, Jeremy S. Abramson, Gilles A. Salles, Jason Westin. "Phase 2 trial of lisocabtagene maraleucel for minimal residual disease in patients with large B-cell lymphoma.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps7107